
- Volume 0 0
FDA DISPUTES MEDIA REPORTS ON NEWER CONTRACEPTIVES
FDA officials are advising pharmacistsand patients to disregard recent news storiesthat they say "have created misperceptionsabout the effectiveness of newergenerationhormonal contraceptives."
According to the FDA, "the stories inaccuratelyreport that the products are significantlyless effective at preventing pregnancythan those approved decades ago."In truth, agency officials said, the newer-generationproducts are "highly effective."
The stories mistakenly suggested thatthe agency called a meeting to discuss theneed for higher standards of efficacy forthe newer products.
In reality, FDA officials said, the purposeof the meeting was "to discuss clinical trialdesigns that reflect the diversity of usersof hormonal contraceptives, expectationsfor efficacy and safety, and user acceptabilityof the newer-generation products,including cycle control."
Articles in this issue
over 18 years ago
HIVover 18 years ago
compounding HOTLINEover 18 years ago
Miller Rises Above with Ambitious Attitudeover 18 years ago
Project AWAREover 18 years ago
Pharmacies' Lawsuit Against PBMs Won on Appealover 18 years ago
E-Rx Innovation Hits Nation's Capital...over 18 years ago
...And E-Rx Is Available to Every Physicianover 18 years ago
Enhanced Messaging Targets Specific Groupsover 18 years ago
Resource Helps Patients Navigate Health Care Environmentover 18 years ago
PDAs Help Pharmacists Deliver The Best Care, AnywhereNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.